Your browser doesn't support javascript.
loading
Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma.
Molinaro, Roberto; Martinez, Jonathan O; Zinger, Assaf; De Vita, Alessandro; Storci, Gianluca; Arrighetti, Noemi; De Rosa, Enrica; Hartman, Kelly A; Basu, Nupur; Taghipour, Nima; Corbo, Claudia; Tasciotti, Ennio.
Afiliação
  • Molinaro R; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA and School of Pharmacy, Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.
  • Martinez JO; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.
  • Zinger A; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.
  • De Vita A; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA and Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Storci G; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA and Departmentof Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
  • Arrighetti N; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA and Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Rosa E; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.
  • Hartman KA; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.
  • Basu N; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.
  • Taghipour N; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA.
  • Corbo C; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA and School of Medicine and Surgery, Nanomedicine Center NANOMIB, University of Milano-Bicocca, Milano, Italy. claudia.corbo@unimib.it.
  • Tasciotti E; Regenerative Medicine Program, Houston Methodist Research Institute, Houston, TX, USA and Houston Methodist Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA. etasciotti@houstonmethodist.org.
Biomater Sci ; 8(1): 333-341, 2020 Jan 01.
Article em En | MEDLINE | ID: mdl-31714542
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Nanopartículas / Melanoma Limite: Animals Idioma: En Revista: Biomater Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Nanopartículas / Melanoma Limite: Animals Idioma: En Revista: Biomater Sci Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália País de publicação: Reino Unido